About Hospira News & Media Investor RelationsIn the CommunitySearch:   
Financial Reports
Annual Reports/
Proxies
Quarterly Reports/
Supplemental Tables
2010 Proxy Materials
SEC Filings
Insider Transactions
Tax Information for Shareholders
Investing Overview
Stock Quote
Stock Chart
Shareholder FAQ
Analyst Coverage
News & Events
Press Releases
Presentations
IR Calendar
Email Alerts  
Corporate Governance
Hospira Leadership
Board of Directors
Board Committees
and Charters
Corporate Governance
Guidelines
Share Ownership Guidelines
Long Term
Incentives Policy
Hospira Code of Business Conduct

Analyst Coverage
FirmAnalyst
Bank of America / Merrill LynchGregg Gilbert
Bernstein ResearchAaron (“Ronny”)  Gal
Buckingham ResearchDavid Buck
C.L. King & Associates Robert  Goldman
Capstone InvestmentsJohn  Putnam
CitigroupGregory Hertz
Goldman SachsDavid Roman
J.P. MorganChristopher  Schott
Leerink SwannRick Wise
Morgan StanleyMarshall Urist
Raymond JamesJayson Bedford
 Edward Han-Burgess
Soleil Securities CorporationJunaid Husain
Hospira is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Hospira's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Hospira or its management. Hospira does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
This Web site and its information is intended for use by United States residents only. Countries outside the United States may have regulatory requirements, data requirements or medical practices that differ from the United States and, therefore, this information may be inappropriate for use outside the United States. Site contents are intended for informational purposes only and not intended to replace discussion with a healthcare provider. If you have any questions regarding this site, contact Hospira.

9-084-IR